Effects of Direct Current Administration on Hyperhidrosis Disease Severity Scale in Patients with Axillary Hyperhidrosis
- PMID: 31781610
- PMCID: PMC6875350
- DOI: 10.1155/2019/3232015
Effects of Direct Current Administration on Hyperhidrosis Disease Severity Scale in Patients with Axillary Hyperhidrosis
Abstract
Background: Focal hyperhidrosis mostly affects the axillae, hands, feet, and face. For the management, several techniques are used. The aim of this study was to investigate the effects of direct current administration on the hyperhidrosis disease severity scale (HDSS) in patients with axillary hyperhidrosis that have various HDSS scores.
Design and setting: Original article, University Hospital.
Methods: Sixty patients with primary axillary hyperhidrosis were inquired about the HDSS scores and the scores were noted at the onset and at the end of the 10th application. One month after the last session, HDSS scores were also inquired. At the end of 1-month follow-up, the patients whose HDSS scores rose after the 10th session were accepted as nonresponder. For the current delivery, a new iontophoresis application module (Sweat CureR) designed by Dr. Karakoc was used.
Results: Direct current application decreased axillary sweat intensity by 70% at both sides, and lowered the HDSS by about 1.5 degree. Major reduction in sweat intensity was in the patients with low HDSS scores (75%). Negative correlation was found between initial HDSS scores and median values of decreased sweat intensity (r = -0.317, p = 0.022). Minimal temporary side effects including skin irritation and one or more vesicle formation were inspected in 29 patients and, the permanent punctual pigmentation was observed only in one patient.
Conclusions: Decrease in axillary hyperhidrosis is satisfactory for these patients. Since iontophoresis application has beneficial effect and minimal side effects, it should be recommended to the patients before advanced management or surgical techniques.
Copyright © 2019 Serpil Şener and Yunus Karakoç.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study.Australas J Dermatol. 2015 Nov;56(4):279-84. doi: 10.1111/ajd.12260. Epub 2014 Dec 13. Australas J Dermatol. 2015. PMID: 25496000 Clinical Trial.
-
Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.Lasers Surg Med. 2023 Jan;55(1):105-115. doi: 10.1002/lsm.23610. Epub 2022 Oct 13. Lasers Surg Med. 2023. PMID: 36229952 Free PMC article. Clinical Trial.
-
Clinical evaluation of a microwave device for treating axillary hyperhidrosis.Dermatol Surg. 2012 May;38(5):728-35. doi: 10.1111/j.1524-4725.2012.02375.x. Epub 2012 Mar 27. Dermatol Surg. 2012. PMID: 22452511 Free PMC article.
-
[Management of hyperhidrosis].Ann Dermatol Venereol. 2015 Apr;142(4):252-61. doi: 10.1016/j.annder.2014.11.005. Epub 2015 Feb 16. Ann Dermatol Venereol. 2015. PMID: 25697587 Review. French.
-
Current treatments for axillary hyperhidrosis.Surgeon. 2004 Dec;2(6):311-4, 360. doi: 10.1016/s1479-666x(04)80028-3. Surgeon. 2004. PMID: 15712569 Review.
Cited by
-
Lumbar Sympathetic Nerve Modulation Using Absolute Ethanol for the Treatment of Primary Lower-Extremity Hyperhidrosis: A Dose-Effect Pilot Study.Med Sci Monit. 2021 Jan 12;27:e928209. doi: 10.12659/MSM.928209. Med Sci Monit. 2021. PMID: 33434188 Free PMC article.
-
Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A-Observational Study.Toxins (Basel). 2024 Jul 16;16(7):320. doi: 10.3390/toxins16070320. Toxins (Basel). 2024. PMID: 39057960 Free PMC article.
-
Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review.Qual Life Res. 2022 Mar;31(3):671-686. doi: 10.1007/s11136-021-02958-3. Epub 2021 Jul 30. Qual Life Res. 2022. PMID: 34327635 Free PMC article.
References
-
- Solish N., Bertucci V., Dansereau A., et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the canadian hyperhidrosis advisory committee. Dermatologic Surgery. 2007;33(8):908–923. doi: 10.1097/00042728-200708000-00003. - DOI - PubMed
-
- Thomas I., Brown J., Vafaie J., Schwartz R. A. Palmoplantar hyperhidrosis: a therapeutic challenge. American Family Physician. 2004;69(5):1117–1120. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources